A marriage of formal methods and LLMs seeks to harness the strengths of both.
Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...
The new coding model released Thursday afternoon, entitled GPT-5.3-Codex, builds on OpenAI’s GPT-5.2-Codex model and combines insights from the AI company’s GPT-5.2 model, which excels on non-coding ...
Finding the right book can make a big difference, especially when you’re just starting out or trying to get better. We’ve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results